Question: is inotuzumab ozogamicin approved by fda?
Answer: FDA approves inotuzumab ozogamicin for relapsed or refractory B-cell precursor ALL. On Aug. 17, 2017, the U.S. Food and Drug Administration approved inotuzumab ozogamicin (BESPONSA, Wyeth Pharmaceuticals Inc., a subsidiary of Pfizer Inc.)